BioLine RX Ltd (NASDAQ:BLRX)
| 1.30 Delayed Data As of Jun 28 |  -0.01 / -0.76%Today’s Change | 1.01 Today|||52-Week Range 3.62 | -36.27% Year-to-Date |
Latest BLRX News | Press Releases
No recent news for BioLine RX Ltd.
Today’s Trading
| Previous close | 1.31 |
| Today’s open | 1.37 |
| Day’s range | 1.27 - 1.37 |
| Volume | 147,559 |
| Average volume (3 months) | 184,516 |
| Market cap | $64.5M |
Data as of 3:59pm ET, 06/28/2022
Growth & Valuation
| Earnings growth (last year) | +65.63% |
| Earnings growth (this year) | +8.71% |
| Earnings growth (next 5 years) | -25.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBIOMustang Bio Inc | -0.07 | -10.63% |
| SCYXSCYNEXIS Inc | -0.08 | -4.06% |
| FBIOPFortress Biotech Inc | -0.56 | -3.04% |
| OPNTOpiant Pharmaceutica... | +0.31 | +2.64% |
Data as of 4:00pm ET, 06/28/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Modi'in, Hamerkaz |
Forecasts
